| Mathematical modeling of prostate cancer progression in response to androgen ablation therapy HV Jain, SK Clinton, A Bhinder, A Friedman Proceedings of the National Academy of Sciences 108 (49), 19701-19706, 2011 | 85 | 2011 |
| A Confidence Building Exercise in Data and Identifiability: Modeling Cancer Chemotherapy as a Case Study MC Eisenberg, HV Jain Journal of Theoretical Biology, 2017 | 64 | 2017 |
| Modeling the VEGF–Bcl-2–CXCL8 Pathway in Intratumoral Agiogenesis HV Jain, JE Nör, TL Jackson Bulletin of mathematical biology 70 (1), 89-117, 2008 | 53 | 2008 |
| The molecular basis of synergism between carboplatin and ABT-737 therapy targeting ovarian carcinomas HV Jain, M Meyer-Hermann Cancer research 71 (3), 705-715, 2011 | 50 | 2011 |
| Modeling prostate cancer response to continuous versus intermittent androgen ablation therapy HV Jain, A Friedman Discrete Contin. Dyn. Syst. B 18, 945-967, 2013 | 36 | 2013 |
| Level of endothelial cell apoptosis required for a significant decrease in microvessel density Z Dong, BD Zeitlin, W Song, Q Sun, E Karl, DM Spencer, HV Jain, ... Experimental cell research 313 (16), 3645-3657, 2007 | 32 | 2007 |
| A Biomechanical Model of Tumor-induced Intracranial Pressure and Edema in Brain Tissue IC Sorribes, MNJ Moore, HM Byrne, HV Jain Biophysical Journal 116 (8), 1560-1574, 2019 | 30 | 2019 |
| Quantification of endothelial cell–targeted anti–Bcl-2 therapy and its suppression of tumor growth and vascularization HV Jain, JE Nör, TL Jackson Molecular cancer therapeutics 8 (10), 2926-2936, 2009 | 28 | 2009 |
| A hybrid model of the role of VEGF binding in endothelial cell migration and capillary formation HV Jain, TL Jackson Frontiers in oncology 3, 2013 | 26 | 2013 |
| Mathematical Modeling of Cellular Cross-Talk Between Endothelial and Tumor Cells Highlights Counterintuitive Effects of VEGF-Targeted Therapies H Jain, T Jackson Bulletin of Mathematical Biology, 1-46, 2017 | 23 | 2017 |
| Mitigating Temozolomide Resistance in Glioblastoma via DNA Damage-Repair Inhibition IC Sorribes, SK Handelman, HV Jain Royal Society Interface 17, 2020 | 21 | 2020 |
| Standing Variations Modeling Captures Inter-Individual Heterogeneity in a Deterministic Model of Prostate Cancer Response to Combination Therapy HV Jain, IC Sorribes, SK Handelman, J Barnaby, TL Jackson Cancers 13 (8), 1872, 2021 | 15 | 2021 |
| Exploiting the Synergy between Carboplatin and ABT-737 in the Treatment of Ovarian Carcinomas HV Jain, A Richardson, M Meyer-Hermann, HM Byrne PloS one 9 (1), e81582, 2014 | 15 | 2014 |
| A partial differential equation model of metastasized prostatic cancer. A Friedman, HV Jain Mathematical biosciences and engineering: MBE 10 (3), 591-608, 2013 | 15 | 2013 |
| Qualitative analysis of an integro-differential equation model of periodic chemotherapy HV Jain, HM Byrne Applied Mathematics Letters 25 (12), 2132-2136, 2012 | 14 | 2012 |
| Modeling stem/progenitor cell-induced neovascularization and oxygenation around solid implants HV Jain, NI Moldovan, HM Byrne Tissue Engineering Part C: Methods 18 (7), 487-495, 2012 | 12 | 2012 |
| Hybrid Modelling of transarterial chemoembolisation therapies (tAce) for Hepatocellular carcinoma (Hcc) H Perfahl, HV Jain, T Joshi, M Horger, N Malek, M Bitzer, M Reuss Scientific reports 10 (1), 1-13, 2020 | 10 | 2020 |
| Modeling hepatitis C virus protein and p53 interactions in hepatocytes: Implications for carcinogenesis MI Poole, I Sorribes, HV Jain Mathematical biosciences 306, 186-196, 2018 | 10 | 2018 |
| Relating prostate‐specific antigen leakage with vascular tumor growth in a mathematical model of prostate cancer response to androgen deprivation JP Barnaby, IC Sorribes, HV Jain Computational and Systems Oncology, e1014, 2021 | 7 | 2021 |
| SMoRe ParS: A novel methodology for bridging modeling modalities and experimental data applied to 3D vascular tumor growth HV Jain, KA Norton, BB Prado, TL Jackson Frontiers in Molecular Biosciences 9, 2022 | 5 | 2022 |
Inmaculada C. SorribesPMx - Integrated Drug Development, Certara Strategic Consulting在 certara.com 的电子邮件经过验证
